ProFem GmbH
🇦🇹Austria
Clinical Trials
5
Active:4
Completed:1
Trial Phases
2 Phases
Phase 1:3
Phase 2:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (5 trials with phase data)• Click on a phase to view related trials
Phase 1
3 (60.0%)Phase 2
2 (40.0%)A Phase IIb/III Study of Prof-001 for the Treatment of Patients With Recurrent Vulvovaginal Candidiasis (RVVC)
Phase 2
Active, not recruiting
- Conditions
- Recurrent Vulvovaginal Candidiasis
- Interventions
- First Posted Date
- 2021-02-02
- Last Posted Date
- 2022-09-22
- Lead Sponsor
- ProFem GmbH
- Target Recruit Count
- 432
- Registration Number
- NCT04734405
- Locations
- 🇦🇹
Ordination Dr. Nehoda, Innsbruck, Tirol, Austria
🇦🇹Universitätsklinik für Gynäkologie und Geburthilfe, Uni-Klinik IBK, Innsbruck, Tirol, Austria
🇦🇹Ordination Dr. Mayr, Kufstein, Tirol, Austria
ProF-001_Phase IIa
Phase 2
Completed
- Conditions
- Vulvovaginal Candidiasis (VVC)
- Interventions
- First Posted Date
- 2017-04-14
- Last Posted Date
- 2019-03-14
- Lead Sponsor
- ProFem GmbH
- Target Recruit Count
- 84
- Registration Number
- NCT03115073
- Locations
- 🇦🇹
Medical University Innsbruck, Innsbruck, Austria
🇦🇹Bezirkskrankenhaus Schwaz, Schwaz, Austria
🇦🇹Medical University Vienna, Vienna, Austria
News
No news found